SNP ID | Position | Alleles | Trait | Variation Type |
---|---|---|---|---|
rs7069964 | chr10:67486714 (GRCh38.p7) | C>T | alcohol dependence | SNV(Single Nucleotide Variation) |
rs10997651 | chr10:67462712 (GRCh38.p7) | A>C | alcohol dependence | SNV(Single Nucleotide Variation) |
rs2394340 | chr10:67101514 (GRCh38.p7) | T>C | alcohol dependence | SNV(Single Nucleotide Variation) |
rs9332406 | chr10:66910441 (GRCh38.p7) | C>A | nicotine dependence | SNV(Single Nucleotide Variation) |
rs4142041 | chr10:66881193 (GRCh38.p7) | A>G | nicotine dependence | SNV(Single Nucleotide Variation) |
rs1880046 | chr10:66878053 (GRCh38.p7) | C>T | nicotine dependence | SNV(Single Nucleotide Variation) |
rs10997361 | chr10:66722696 (GRCh38.p7) | C>T | alcohol dependence | SNV(Single Nucleotide Variation) |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
SLCO1A2 | 0.927 |
MOBP | 0.916 |
PAIP2B | 0.907 |
LPAR1 | 0.896 |
ZFP57 | 0.896 |
ERMN | 0.891 |
ZEB2 | 0.882 |
ARHGEF37 | 0.882 |
BCAS1 | 0.879 |
RASSF2 | 0.878 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
PCDH8 | -0.612 |
CUX2 | -0.59 |
CDH22 | -0.568 |
POU3F1 | -0.563 |
KCNK3 | -0.554 |
ASB2 | -0.548 |
KCNQ4 | -0.544 |
SHROOM3 | -0.544 |
HCN4 | -0.54 |
IGSF3 | -0.534 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
D020106 | Acrylamide | Acrylamide results in decreased expression of CTNNA3 mRNA | 28959563 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased methylation of CTNNA3 gene | 27153756 |
C006780 | bisphenol A | bisphenol A affects the expression of CTNNA3 mRNA | 25181051 |
C013418 | bromfenacoum | bromfenacoum results in increased expression of CTNNA3 protein | 28903499 |
D003471 | Cuprizone | Cuprizone results in decreased expression of CTNNA3 mRNA | 27523638 |
D003485 | Cyanates | CTNNA3 SNP results in increased susceptibility to Cyanates | 22977168 |
D003999 | Dichloroacetic Acid | Dichloroacetic Acid results in decreased expression of CTNNA3 mRNA | 28962523 |
C008261 | lead acetate | lead acetate results in increased expression of CTNNA3 mRNA | 22641619 |
D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CTNNA3 mRNA" | 26251327 |
D009151 | Mustard Gas | Mustard Gas results in decreased expression of CTNNA3 mRNA | 18988085 |
C028007 | nickel monoxide | nickel monoxide results in decreased expression of CTNNA3 mRNA | 19167457 |
D010634 | Phenobarbital | Phenobarbital results in decreased expression of CTNNA3 mRNA | 19084549 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CTNNA3 mRNA | 19710929 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of CTNNA3 mRNA | 20813756 |
D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of CTNNA3 mRNA | 24780913 |
C017947 | sodium arsenite | sodium arsenite affects the methylation of CTNNA3 gene | 28589171 |
D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of CTNNA3 mRNA | 27862939 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CTNNA3 mRNA | 21570461 |
D001335 | Vehicle Emissions | Vehicle Emissions affects the methylation of CTNNA3 gene | 25560391 |
C025643 | vinclozolin | vinclozolin results in decreased expression of CTNNA3 mRNA | 22570695 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005515 | protein binding | - | IPI | 11590244 22190034 23136403 |
GO:0008013 | beta-catenin binding | - | IPI | 23136403 |
GO:0045296 | cadherin binding | - | TAS | 11590244 |
GO:0051015 | actin filament binding | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication | - | IMP | 23136403 |
GO:0086091 | regulation of heart rate by cardiac conduction | - | IMP | 23136403 |
GO:0098609 | cell-cell adhesion | - | IPI | 11590244 |
GO:0098911 | regulation of ventricular cardiac muscle cell action potential | - | IMP | 23136403 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005737 | cytoplasm | - | IEA | - |
GO:0005856 | cytoskeleton | - | IEA | - |
GO:0005916 | fascia adherens | - | IDA | 11590244 |
GO:0030027 | lamellipodium | - | IEA | - |
KEGG ID | KEGG Term |
---|---|
hsa04520 | Adherens junction |
hsa04530 | Tight junction |
hsa04670 | Leukocyte transendothelial migration |
hsa05100 | Bacterial invasion of epithelial cells |
hsa05200 | Pathways in cancer |
hsa05213 | Endometrial cancer |
hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) |
Reactome ID | Reactome Term | Evidence |
---|
PMID | Title (Year) | Author | Journal |
---|---|---|---|
24890784 | Exon microarray analysis of human dorsolateral prefrontal cortex in alcoholism. (2014 Jun) | Manzardo AM | Alcohol Clin Exp Res |
27613936 | High Prevalence of Smoking in the Roma Population Seems to Have No Genetic Background. (2016 Dec) | Fiatal S | Nicotine Tob Res |
25781172 | Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variation. (2015) | Avramopoulos D | PLoS One |
22977168 | CTNNA3 (alpha-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population. (2013 Jan) | Bernstein DI | Toxicol Sci |
20675872 | [Risk factors for Alzheimer's disease]. (2010 Jul) | Ikeda T | Brain Nerve |